CRISPR-Cas9-mediated gene therapy in lung cancer
Crossref DOI link: https://doi.org/10.1007/s12094-022-03039-8
Published Online: 2022-12-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kazemizadeh, Hossein
Kashefizadeh, Alireza https://orcid.org/0000-0001-7997-0365
Text and Data Mining valid from 2022-12-10
Version of Record valid from 2022-12-10
Article History
Received: 4 July 2022
Accepted: 25 November 2022
First Online: 10 December 2022
Declarations
:
: None.
: It is not applicable.